Krm Ayurveda Ltd. · NSE:KRMAYURVED
Krm Ayurveda — Q1 FY27 Earnings Presentation
5 slides from Krm Ayurveda's earnings presentation, Aug 10, 2026
Slide 1: Submission of Presentation on Un-Audited Standalone Financial Results
KRM AYURVEDA LTD (Formerly Known as KRM Ayurveda Private Limit ed) 10t* August, 2026 SYMBOL: KRMAYURVED To The Manager National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra East Mumbai- 400 051 Sub: Submission of Presentation on the Un-Audited Standalone Financial Result
Slide 2: Q1 FY27 Results
KRM AYURVEDA LIMITED Q1 FY27 Results Quarter ended 30 June 2026 - Integrated Ayurvedic healthcare & weliness TOTAL INCOME EBITDA NET PROFIT (PAT) EBITDA MARGIN 3,286.55 1,256.07 908.45 38.22% ® Lakhs ® Lakhs ® Lakhs of total income 432.4% YoY +1.4% QoQ 497.4% YoY +12.4% QoQ 4+124.2% YoY +16.3% QoQ +
Slide 3: EBITDA & PAT — Q1 Growth
PROFITABILITY EBITDA & PAT — Q1 Growth Year-on-year against Qi FY26 and sequential against Q4 FY26 » & Lakhs Q1 YEAR-ON-YEAR > Ql FY27 QLFY26 Q1 QUARTER-ON-QUARTER Q4FY26 > QIFY27 1,256 1,256 1,118 908 908 781 636 405 EBITDA PAT EBITDA PAT QLFY26 mQ1FY27 Q4FY26 mQ1FY27 EBITDA growth +9 TAY PAT growt
Slide 4: Hospital & Services — Capacity-Led Growth
CORE FOCUS AREA Hospital & Services — Capacity-Led Growth Incremental beds converting to revenue as new facilities ramp up » = Lakhs 2,392.20 L SERVICES REVENUE TREND Q1 FY26 > Q1 FY27 2,392 Q1 FY27 SERVICES REVENUE 1,495 1,643 +109.8% YoY - +45.6% QoQ 4,140 4,191 C= —~ = 5,468 L FY26 SERVICES REVEN
Slide 5: Owned D2C Platform Goes Live in Q2 FY27
PRODUCT BUSINESS Owned D2C Platform Goes Live in Q2 FY27 % 4,701 L PRODUCT REVENUE BY QUARTER FY26 PRODUCT REVENUE 1,579 Broadly stable vs 2 4,923 Lin FY25 8 Lakh+ YOUTUBE FOLLOWERS Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Owned audience across three channels Q2 FY27 Channel Launch Planned @ Own e-co